Serum CA-125 Level in End-Stage Renal Disease Patients Maintained on Chronic Peritoneal Dialysis or Hemodialysis: The Effect of Continuous Presence of Peritoneal Fluid, Peritonitis, and Peritoneal Catheter Implantation
- 1 January 1995
- journal article
- research article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 15 (6) , 468-472
- https://doi.org/10.1159/000168888
Abstract
Serum CA-12 5 an ovarian tumor marker, is used to screen and follow up patients with ovarian cancer. Normal values ( 35 U/ml. In the CAPD patients, the mean serum CA-125 level in all samples collected (n = 68) was 17.7 ± 2.7 U/ml (range 35 U/ml. The high serum CA-125 levels in the CAPD patients were from sera obtained within 2 months of diagnosis of peritonitis, peritoneal dialysis (PD) catheter implantation, or intra-abdominal surgery. When serum samples from this 2-month period were excluded, the mean serum CA-125 level was 8.9 ± 1.5 U/ml (p = NS vs. HD) and only 1 patient had an abnormal level. Peritoneal dialysate CA-125 levels during an episode of peritonitis were significantly higher than at the baseline (69.1 ± 14.2 vs. 21 ± 2.5, p = 0.004) and both were significantly higher than the serum levels (pKeywords
This publication has 0 references indexed in Scilit: